rOv-ASP-1 adjuvant (DMX)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerOv-ASP-1 adjuvant (DMX)
Drug Alias NameOnchocerca volvulus activation-associated secreted protein-1 (DMX)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDMX Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDMX Inc
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A